EDGAR Filing Documents for 0001829126-21-011457

Form 8-K - Current report:

SEC Accession No. 0001829126-21-011457

Filing Date

2021-10-05

Accepted

2021-10-04 18:55:32

Documents

Period of Report

2021-09-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	inspyrtherap_8k.htm iXBRL	8-K	77604
2	EXHIBIT 2.01	inspyrtherap_ex2-01.htm	EX-2.1	59576
3	EXHIBIT 3.01(I)	inspyrtherap_ex3-01i.htm	EX-3.01(I)	15315
4	EXHIBIT 3.02(I)	inspyrtherap_ex3-02i.htm	EX-3.02(I)	19481
5	EXHIBIT 3.03(II)	inspyrtherap_ex3-03ii.htm	EX-3.03(II)	98515
	Complete submission text file	0001829126-21-011457.txt		487271

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	nspx-20210928.xsd	EX-101.SCH	3025
7	XBRL LABEL FILE	nspx-20210928_lab.xml	EX-101.LAB	34240
8	XBRL PRESENTATION FILE	nspx-20210928_pre.xml	EX-101.PRE	22359
9	EXTRACTED XBRL INSTANCE DOCUMENT	inspyrtherap_8k_htm.xml	XML	3405

Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361

Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112

Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)